Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

TPEX/6467 stock hub

TPEX/6467 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6467is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6467

In the news

Latest news · TPEX/6467

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-48.1

P25 n/aP50 n/aP75 n/a

ROIC-29.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6467 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

154

Groups with data

Currency

TWD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	27
Employees Change	13%
Employees Change Percent	92.86
Enterprise value	TWD 6.6B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	TWD 7B
Price	TWD 137
Price currency	TWD
Rev Per Employee	288,111.11x
Sic	2834
Symbol	tpex/6467
Website	https://www.tahopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.37%
EV Earnings	-39.93x
EV/FCF	-38.54x
FCF yield	-2.45%
P/B ratio	15.74x
P/S ratio	901.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	62.67%
Gross Profit	TWD 4.9M
Net Income	TWD -166M
Pretax Margin	-2,133.5%
Profit Per Employee	TWD -6.1M
ROA	-29.12
ROCE	-37.74
ROE	-48.14
ROIC	-29.66

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	127.11%
Revenue Growth3 Y	93.96x
Revenue Growth5 Y	-8.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.02
Assets	TWD 465.8M
Cash	TWD 401.5M
Current Assets	TWD 404.7M
Current Liabilities	TWD 11.3M
Debt	TWD 14M
Debt Equity	TWD 0.03
Debt FCF	TWD -0.08
Equity	TWD 445.8M
Interest Coverage	-213.3
Liabilities	TWD 20M
Long Term Assets	TWD 61M
Long Term Liabilities	TWD 8.7M
Net Cash	TWD 387.5M
Net Cash By Market Cap	TWD 5.52
Net Cash Growth	93.9%
Net Debt Equity	TWD -0.87
Tangible Book Value	TWD 444.9M
Tangible Book Value Per Share	TWD 8.65
WACC	-182.7

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	35.75
Net Working Capital	TWD -2.7M
Quick ratio	35.53
Working Capital	TWD 393.4M
Working Capital Turnover	TWD 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-17.82%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	126.98%
200-day SMA	137.8
50-day SMA	126.6
50-day SMA vs 200-day SMA	50under200
All Time High	208.5
All Time High Change	-34.53%
All Time High Date	2025-09-04
All Time Low	32.25
All Time Low Change	323.26%
All Time Low Date	2024-12-30
ATR	7.95
Beta	-34.06
Beta1y	0.03
Beta2y	0.13
Ch YTD	22.42
High	145
High52	208.5
High52 Date	2025-09-04
High52ch	-34.53%
Low	129
Low52	45.6
Low52 Date	2025-07-15
Low52ch	199.34%
Ma50ch	7.83%
Price vs 200-day SMA	-0.96%
RSI	65.16
RSI Monthly	63.78
RSI Weekly	52.8
Sharpe ratio	1.4x
Sortino ratio	3
Total Return	-17.82%
Tr YTD	22.42
Tr1m	13.28%
Tr1w	14.23%
Tr3m	6.64%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -171.5M
Operating margin	-2,204.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,862,699%
Net Borrowing	-5,154,000
Shares Insiders	13.09%
Shares Institutions	11.55%
Shares Out	51,390,615
Shares Qo Q	8.65%
Shares Yo Y	17.82%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -172.1M
Average Volume	373,258.85x
Bv Per Share	8.67
CAPEX	TWD -9.5M
Ch1m	13.28
Ch1w	14.23
Ch1y	126.7
Ch3m	6.64
Ch6m	-23.31
Change	5.81%
Change From Open	5.81
Close	129
Days Gap	0
Depreciation Amortization	2,810,000
Dollar Volume	76,298,176.5
Earnings Date	2026-05-13
EBIT	TWD -171.5M
EBITDA	TWD -168.7M
EPS	TWD -3.37
F Score	2
FCF	TWD -172M
FCF EV Yield	-2.59x
FCF Per Share	TWD -3.35
Financing CF	363,391,000
Fiscal Year End	December
Founded	2,010
Investing CF	-318,418,000
Is Primary Listing	1
Last Earnings Date	2025-11-13
Last Report Date	2025-06-30
Ma150	143.9
Ma150ch	-5.12%
Ma20	119.1
Ma20ch	14.59%
Net CF	-117,490,000
Next Earnings Date	2026-05-13
Open	129
Position In Range	46.88
Ppne	25,599,000
Price Date	2026-05-08
Ptbv Ratio	15.77
Relative Volume	1.5x
Revenue	7,779,000x
SBC By Revenue	1.11x
Share Based Comp	86,000
Tr6m	-23.31%
Volume	558,961
Z Score	93.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TPEX/6467 pay a dividend?

Capital-return profile for this ticker.

Performance

TPEX/6467 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6467?

Insider, institutional, and short-interest positioning.

Institutional ownership

+11.6%

Share of float held by funds and institutions

Insider ownership

+13.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+17.8%

Negative means the company is buying back shares.

Technical

TPEX/6467 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.2

Neutral momentum band

Price vs 200-day MA

-1.0%

50/200-day relationship not available

Beta (5Y)

-34.06

Less volatile than the market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6467

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6467 stock rating?

tpex/6467 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6467 analysis?

The full report lives at /stocks/tpex/6467/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6467?

The latest report frames tpex/6467 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6467 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.